Madrigal Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 431.7 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.97B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.